BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3087839)

  • 1. Prognostic significance of serum albumin in Hodgkin's disease.
    Gobbi PG; Cavalli C; Gendarini A; Bonfichi M; Galeone F; Inzoli A; Ascari E
    Haematologica; 1986; 71(2):95-102. PubMed ID: 3087839
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis in Hodgkin's disease: verification of a new predictive equation.
    Bettini R; Quadrelli M; Quadrelli G; Biganzoli L; Venco A
    Haematologica; 1990; 75(5):482. PubMed ID: 2097268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum protein pattern in patients with Hodgkin's disease].
    Glińska H; Adamczyk B
    Pol Tyg Lek; 1969 Jun; 24(26):993-5. PubMed ID: 5805072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior and prognostic significance of serum ceruloplasmin in relation to the histopathological aspect of Hodgkin's disease].
    Pisi E; Di Feliciantonio R; Figus E; Ferri S
    Minerva Med; 1968 Feb; 59(17):944-52. PubMed ID: 5652623
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
    Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
    Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disk electrophoresis, on polyacrylamide gel. II. Variability of serum "patterns" of patients with Hodgkin's disease as compared with those of normal individuals].
    Sega E; Minetti M; Petrucci T
    Boll Ist Sieroter Milan; 1973; 52(3):242-6. PubMed ID: 4762781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mediastinal Hodgkin's disease and non-Hodgkin lymphoma in childhood].
    Kuleva SA
    Vopr Onkol; 2002; 48(6):735-7. PubMed ID: 12530278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification and comparison of two different predictive equations in Hodgkin's disease.
    Bettini R; Tonolini M; Maccianti E
    Haematologica; 1997; 82(3):324-7. PubMed ID: 9234580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum albumin in Hodgkin's disease.
    Gobbi PG; Gendarini A; Crema A; Cavalli C; Attardo-Parrinello G; Federico M; Di Prisco U; Ascari E
    Cancer; 1985 Jan; 55(2):389-93. PubMed ID: 2578086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invited discussion: Approaches to the serologic characterization of Hodgkin's disease.
    Sega E; Isabella F; Minnetti M; Petrucci T; Citro G
    Natl Cancer Inst Monogr; 1973 May; 36():159-62. PubMed ID: 4200712
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's disease.
    Tubiana M; van der Werf-Messing B; Laugier A; Hayat M; Henry-Amar M; Attie E; Leroy T
    Natl Cancer Inst Monogr; 1973 May; 36():513-30. PubMed ID: 4744607
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors in non-Hodgkin's lymphomas].
    Mayáns J; Sanz G; Monzó E; Sancho-Tello R; Carrera MD; Figueres J; Sanz MA
    Rev Clin Esp; 1987 May; 180(8):420-5. PubMed ID: 3616025
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of serum lactic dehydrogenase level in Hodgkin's disease.
    Schilling RF; McKnight B; Crowley JJ
    J Lab Clin Med; 1982 Mar; 99(3):382-7. PubMed ID: 7057064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with Hodgkin's lymphoma.
    Salgami EV; Efstathiou SP; Vlachakis V; Sekara EV; Syrigos KN; Roussou PP
    Haematologia (Budap); 2002; 32(4):377-87. PubMed ID: 12803112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationship between several prognostic factors in Hodgkin's disease.
    Kotlarek-Haus S; Gabryś K; Starzyk H; Sciborski R; Gałazka Z
    Arch Geschwulstforsch; 1982; 52(4):293-301. PubMed ID: 7138241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pretreatment peripheral blood lymphocyte count in 1100 patients with Hodgkin's disease: the prognostic significance and the relationship to the presence of systemic symptoms.
    MacLennan KA; Hudson BV; Jelliffe AM; Haybittle JL; Hudson GV
    Clin Oncol; 1981 Dec; 7(4):333-9. PubMed ID: 7318276
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].
    Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K
    Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.